Seattle、WAにおける1型糖尿病の臨床試験
Seattleとその周辺地域（約30マイル以内）の拠点で、1型糖尿病に関する18件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Type 1 Diabetes Extension Study
被験者募集中観察研究
- Benaroya Research Institute, Seattle
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
被験者募集中第2相
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
被験者募集中第3相
- Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
被験者募集中第1/2相
- Benaroya Research Institute, Seattle
- University of Washington Diabetes Institute, Seattle
Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
被験者募集中第2相
- Benaroya Research Institute, Seattle
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
被験者募集中第2相
- Benaroya Research Institute, Seattle
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
被験者募集中第1/2相
- Seattle Children's Hospital, Seattle
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
被験者募集中第2相
- Benaroya Research Institute at Virginia Mason, Seattle
Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
被験者募集中
- University of Washington, Seattle
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
被験者募集中第2相
- University of Washington, Seattle
Kidney Precision Medicine Project
被験者募集中観察研究
- University of Washington, Seattle
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
被験者募集中第3相
- University of Washington, Seattle
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
被験者募集中第3相
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
被験者募集中
- Seattle Children's, Seattle
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
被験者募集中観察研究
- Benaroya Research Institute, Seattle
InvesT1D: Promoting Adolescent Investment in Diabetes Care
被験者募集中
- Seattle Children's, Seattle
TrialNet Pathway to Prevention of T1D
被験者募集中観察研究健康なボランティア歓迎
- Benaroya Research Institute, Seattle
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
被験者募集中第1相
- Seattle Children's Hospital, Seattle
他の都市における1型糖尿病の試験
- Aurora, CO23件の研究
- Boston, MA21件の研究
- Chicago, IL16件の研究
- New Haven, CT15件の研究
- New York City, NY15件の研究
- Indianapolis, IN14件の研究
- San Francisco, CA14件の研究
- Miami, FL13件の研究
- Gainesville, FL12件の研究
- Philadelphia, PA11件の研究
- Atlanta, GA11件の研究
- Durham, NC10件の研究
Seattleにおける他の研究
- 非小細胞肺癌53件の研究
- がん（全種類）49件の研究
- 前立腺がん42件の研究
- 急性骨髄性白血病40件の研究
- 乳がん39件の研究
- 転移性癌39件の研究
- 大腸癌34件の研究
- 肺がん33件の研究
- 卵巣がん30件の研究
- 多発性骨髄腫22件の研究
- 骨髄異形成症候群21件の研究
- 急性リンパ性白血病21件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。